SCHEMBL2560037

SCHEMBL2560037

O=C1CC(c2ccc(OC(F)F)c3oc4ccncc4c23)CN1Cc1ccc(Cl)cc1F

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.58
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
RIPK3 Q9Y572 2/20 0.33
GRM5 P41594 1/20 0.32
KCNH2 Q12809 1/20 0.32
GRM2 Q14416 1/20 0.32
LMNA P02545 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
CYP17A1 P05093 1/20 0.32
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2563116 0.89 PDE10A (0.59) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2562618 0.89 PDE10A (0.64) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2553598 0.89 PDE10A (0.53) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2557873 0.89 PDE10A (0.69) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL7707777 0.88 PDE10A (0.75) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2556467 0.88 PDE10A (0.63) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2565185 0.88 PDE10A (0.53) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2560180 0.88 PDE10A (0.60) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2563558 0.87 PDE10A (0.55) PDE10APDE4APDE4BPDE4CPDE4D
SCHEMBL2563663 0.87 PDE10A (0.53) PDE10APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO claimed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed